PALO ALTO, Calif., — Cell Biosciences announces the introduction of the Firefly(TM) 3000 automated blotless immunoassay workstation for quantitative measurement of cell signaling and protein expression. The Firefly system is designed to leverage the knowledge and intuition of life science researchers by introducing automated parallel analysis into their laboratory operations. The heart of the Firefly […]

ACD/Labs announced that it has entered into a reseller’s agreement with Applied Biosystems Group (NYSE:ABI), an Applera Corporation business, together with its joint venture partner MDS SCIEX, a division of MDS, Inc. (NYSE:MDZ, TSX:MDS). This agreement allows Applied Biosystems/MDS SCIEX to sell ACD/Labs’ MS Manager, MS Fragmenter, and ChemSketch Software in combination with Applied Biosystems/MDS […]

Boston, MA—PerkinElmer has acquired Agilix, a developer of labeling technology using isobaric mass tags for simultaneous quantification of molecules from multiple samples. “The Agilix multiplex protein labeling technology represents a breakthrough in quantitative proteomics. This leading-edge technology reduces the process workflow in proteomics analysis, and enables more accurate studies in protein expression kinetics and pharmacodynamics,” […]

BOSTON–PerkinElmer, Inc. (NYSE: PKI), a global technology leader in Health Sciences and Photonics,announced the acquisition of Agilix Corporation’s proprietary proteomics technology. Agilix has developed a powerful labeling technology using isobaric mass tags that allows for the simultaneous quantification of molecules, such as proteins, from multiple samples. This technology now brings quantitative proteomics to PerkinElmer customers […]

FOSTER CITY, CA and AUSTIN, TX – Applied Biosystems Group (NYSE: ABI), an Applera Corporation business, announced that it has completed the previously announced acquisition of the Research Products Division of Ambion, Inc., a premium provider of innovative products for the study and analysis of ribonucleic acid (RNA), the central molecule used in gene expression […]

-Provides Entry into High-Growth Optical Imaging Market – – Catalyzes Transformation to Leading Edge Drug Discovery Tools and Services Company – – Enhances Revenue Growth and Profitability Outlook – Hopkinton, Mass., and Alameda, Calif., February 13, 2006— Caliper Life Sciences, Inc. (Nasdaq: CALP), a leading provider of products and services for drug discovery research, and […]

PITTSBURGH, Pa., and HAMBURG, Germany,– Cellomics, Inc., a business unit within the Fisher Biosciences group, and Evotec Technologies GmbH announced today that they have entered into a worldwide, non-exclusive patent license agreement. The agreement will provide Evotec Technologies with Cellomics’ core High Content Screening (HCS) patent portfolio, which includes both broad claims to HCS technology […]

SANTA CLARA, Calif., — Affymetrix Inc. (Nasdaq:AFFX) announced today the launch of the GeneChip(R) Human Tiling 1.0R Array Set and Mouse 1.1R Array Set, the only commercially available microarrays for whole-genome transcript mapping. These new arrays look far beyond the known protein-coding genes to deliver the most detailed and unbiased view of the entire human […]

PALO ALTO, Calif., and TOKYO, Japan, — HP (NYSE, Nasdaq: HPQ) and Hitachi, Ltd. (NYSE:HIT/TSE:6501) today announced that researchers from HP Labs Bristol, UK., and Princeton, N.J., and the Hitachi Systems Development Laboratory, will conduct joint work on key security and privacy issues. The HP and Hitachi research collaboration will focus on two primary themes: […]

PerkinElmer, Inc. (NYSE: PKI), a leading provider of drug discovery, life science research, and analytical solutions, and Luminex(R) Corporation (Nasdaq: LMNX), a leading multiplex solution developer, announced today a long-term licensing agreement to provide PerkinElmer access to Luminex’s xMAP(R) technology and assay development capabilities of the Luminex Bioscience Group. Under the terms of the agreement, […]